Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RRC✓SelectedUSD · RRCGSK vs RRC performance historyLatest closeAs of-1.23%11/11
Stock and ETF performance explorer

GSK vs RRC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.9%
RRC return
+72.2%
Excess return
+30.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioRRCExcessAlpha
1D-1.2%+1.3%-2.5%-1.3%
7D-1.1%-0.5%-0.6%-1.1%
30D+7.8%+25.2%-17.4%+7.0%
3M+0.3%+27.8%-27.5%-0.5%
6M+3.4%+27.2%-23.8%+2.6%
YTD+5.9%+48.2%-42.3%+4.4%
1Y+8.2%+34.7%-26.5%+7.0%
3Y+65.3%+62.2%+3.0%+61.7%
5Y+43.3%+130.9%-87.6%+37.1%
10Y+102.9%+73.4%+29.5%+80.9%
All+102.9%+72.2%+30.7%+80.9%

Cumulative growth

Daily Returns

Daily percentage return beside RRC.

Daily Out/Under-Performance

Portfolio return minus RRC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RRC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded RRC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling